Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History
Clinical trial NCT02138916 · COMPLETED
Trial details
- NCT number
- NCT02138916
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-13
- Primary completion
- 2018-04-10
- Enrollment
- 1656
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.